SS
CVAC

Steve Schonfeld’s CureVac CVAC Stock Holding History

Steve Schonfeld’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-275,300
Closed -$1.16M – 2123
2023
Q4 		$1.16M Buy
+275,300
New +$1.49M 0.01% 980
2023
Q2 		– Sell
-23,700
Closed -$165K – 2205
2023
Q1 		$165K Buy
+23,700
New +$207K ﹤0.01% 1584
2022
Q4 		– Sell
-39,100
Closed -$308K – 2663
2022
Q3 		$308K Buy
+39,100
New +$456K ﹤0.01% 2062
2022
Q2 		– Sell
-45,756
Closed -$897K – 2614
2022
Q1 		$897K Buy
+45,756
New +$914K 0.01% 1048
2021
Q4 		– Sell
-12,898
Closed -$710K – 2209
2021
Q3 		$710K Buy
12,898
+7,246
+128% +$437K 0.01% 1110
2021
Q2 		$424K Buy
+5,652
New +$565K ﹤0.01% 1272

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Steve Schonfeld's CVAC Position: Q1 2024 in Review

Steve Schonfeld sold out of CureVac (CVAC) in Q1 2024, closing a stake of 275,300 shares — an estimated $1.16M sold.

Steve Schonfeld first reported a position in CVAC in Q2 2021 and held it in 6 quarters. The position peaked at $1.16M in Q4 2023. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Steve Schonfeld reported no remaining CureVac position as of Q1 2024 after selling out during the quarter.
  • Steve Schonfeld sold 275,300 CureVac shares in Q1 2024, an estimated $1.16M.
  • Steve Schonfeld first reported a position in CureVac in Q2 2021 and held it in 6 quarters.
  • Steve Schonfeld's CureVac position peaked at $1.16M in Q4 2023.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.